Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Rani Therapeutics Holdings, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 38 | 39 | +1 |
| Shares | 3.61M | 6.46M | +2.85M (+78.9%) |
| Value | $4.58M | $3.32M | −$1.26M (−27.5%) |
New holders (7)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 3,151,354 | $1.62M | 0.06% |
| Citadel Advisors LLC | 137,349 | $70.6K | 0.00% |
| Well Done, LLC | 52,014 | $26.7K | 0.01% |
| Tower Research Capital LLC (TRC) | 9,285 | $4.77K | 0.00% |
| Raymond James Financial Inc | 2,954 | $1.52K | 0.00% |
| Ameritas Advisory Services, LLC | 280 | $144 | 0.00% |
| Royal Bank of Canada | 31 | $0 | 0.00% |
Sold out (6)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Alphabet Inc. | 448,492 | $565.1K |
| Forefront Wealth Partners, LLC | 65,000 | $81.9K |
| Susquehanna International Group, LLP | 16,554 | $20.9K |
| XTX Topco Ltd | 10,996 | $13.9K |
| Citigroup Inc | 313 | $394 |
| Stonebridge Financial Group, LLC | 100 | $126 |